• Core Excipients

  • Functional Excipients for the Formulation of Solid Oral Dosage Forms

  • Coatings

  • Fully Formulated Conventional and Modified Release Film Coating Systems
  • Formulation Tools

  • Useful Tools for the Pharmaceutical Formulator

  • Education

  • Technical Formulation and Development Seminars and Forums
  • Evaluate

  • Competitor, Consumer Color Preference, Regulatory, Tablet Library of Shapes, and Trademarks

  • Develop

  • Unique Tablet Designs and Branding Solutions

  • Visualize

  • Concept to Prototypes using State-of-the-Art 3D Images and Models through our Tablet Design Centers

  • Brand Security

  • Understand Options and Learn of New Technologies to Protect your Brand
  • Technical

  • Global Technical Support, Technical Service Labs and Tablet Design Centers

  • Regulatory

  • Global Regulatory Support Services

  • Customer

  • Global Customer Support and Service Locations
  • Tools

  • Useful Tools to Assist Pharmaceutical Product Development

  • Literature

  • Extensive Collection of Articles, Product Literature, Application Data and Regulatory Documents

  • Education

  • Technical Formulation and Development Seminars and Forums
 

Low Dose Formulation

 

Advances in pharmaceutical research have resulted in the development of high potency active ingredients, which can be difficult to formulate into capsules or tablets. The use of Starch 1500® partially pregelatinized maize starch as an active-premix in low dose formulations can provide consistent drug uniformity, which allows manufacturing by a direct compression process. Since many low dose medications are manufactured by a wet granulation method to assure each tablet contains the proper amount of active, switching to a direct compression process can result in substantial savings in total process time and cost.
Update My Binder
Published Posters
Published White Papers/Articles